For People Who Are Moderately or Severely Immunocompromised

5 Through 11 Years of Age: Unvaccinated

People 5 through 11 years of age should receive:

  • An initial 3-dose vaccine series from the same manufacturer
  • Dose 4 can be Moderna or Pfizer-BioNTech

May receive additional doses of Moderna or Pfizer-BioNTech 2024-2025 COVID-19 vaccine under shared clinical-decision making at least 8 weeks after the last dose

*Minimum interval 8 weeks

Reference: Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC and 2024-2025 COVID-19 Vaccine Immunization Schedule for People 6 Months of Age and Older (cdc.gov)

Next
Next
Page last reviewed: November 12, 2024